type here...

CATEGORIES

Breaking Research

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

AI in Public Health: Revolution, Risk and Opportunity

Christopher Nial -
ntroduction Artificial Intelligence (AI) is rapidly reshaping public health — from enhancing disease surveillance and diagnostics to easing workforce burdens — but it also raises...

NAMI Poll: Parents Want Mental Health Education in Schools, Mental Health Days Off for Students

Medika Life -
ARLINGTON, Va., Dec. 15, 2021 /PRNewswire/ -- An overwhelming number of parents support mental health education in schools and "mental health days" for their children, according...

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories